ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
RaceOncology
|
906 |
274K |
101 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
906
|
274K
|
101
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
RaceOncology
|
906 |
274K |
78 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
906
|
274K
|
78
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
RaceOncology
|
906 |
274K |
48 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
906
|
274K
|
48
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
RaceOncology
|
22K |
7.8M |
11 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
22K
|
7.8M
|
11
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
RaceOncology
|
22K |
7.8M |
30 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
22K
|
7.8M
|
30
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
RaceOncology
|
22K |
7.8M |
27 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
22K
|
7.8M
|
27
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
RaceOncology
|
22K |
7.8M |
15 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
22K
|
7.8M
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
RaceOncology
|
146 |
45K |
36 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
146
|
45K
|
36
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
RaceOncology
|
146 |
45K |
34 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
146
|
45K
|
34
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
RaceOncology
|
146 |
45K |
58 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
146
|
45K
|
58
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
RaceOncology
|
146 |
45K |
47 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
146
|
45K
|
47
|
|
ASX - By Stock
|
RAC |
Re:
RAC - Crystal ball gazing
|
|
RaceOncology
|
38 |
8.2K |
37 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
38
|
8.2K
|
37
|
|
ASX - By Stock
|
RAC |
Re:
RAC - Crystal ball gazing
|
|
RaceOncology
|
38 |
8.2K |
26 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
38
|
8.2K
|
26
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
RaceOncology
|
168 |
48K |
20 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
168
|
48K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
RaceOncology
|
146 |
45K |
52 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
146
|
45K
|
52
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
RaceOncology
|
146 |
45K |
20 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
146
|
45K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
RaceOncology
|
146 |
45K |
73 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
146
|
45K
|
73
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
RaceOncology
|
146 |
45K |
63 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
146
|
45K
|
63
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
RaceOncology
|
146 |
45K |
51 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
146
|
45K
|
51
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
RaceOncology
|
146 |
45K |
20 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
146
|
45K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
RaceOncology
|
146 |
45K |
95 |
14/07/24 |
14/07/24 |
ASX - By Stock
|
146
|
45K
|
95
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
RaceOncology
|
906 |
274K |
26 |
14/07/24 |
14/07/24 |
ASX - By Stock
|
906
|
274K
|
26
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
RaceOncology
|
906 |
274K |
62 |
14/07/24 |
14/07/24 |
ASX - By Stock
|
906
|
274K
|
62
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
RaceOncology
|
146 |
45K |
54 |
14/07/24 |
14/07/24 |
ASX - By Stock
|
146
|
45K
|
54
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
RaceOncology
|
130 |
38K |
33 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
130
|
38K
|
33
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
RaceOncology
|
391 |
84K |
93 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
391
|
84K
|
93
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
RaceOncology
|
130 |
38K |
51 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
130
|
38K
|
51
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
RaceOncology
|
391 |
84K |
108 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
391
|
84K
|
108
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
RaceOncology
|
391 |
84K |
29 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
391
|
84K
|
29
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
RaceOncology
|
391 |
84K |
63 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
391
|
84K
|
63
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
RaceOncology
|
391 |
84K |
85 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
391
|
84K
|
85
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
RaceOncology
|
391 |
84K |
44 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
391
|
84K
|
44
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
RaceOncology
|
391 |
84K |
33 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
391
|
84K
|
33
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
RaceOncology
|
391 |
84K |
32 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
391
|
84K
|
32
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
RaceOncology
|
391 |
84K |
37 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
391
|
84K
|
37
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
11K |
4.1M |
43 |
08/07/24 |
08/07/24 |
General
|
11K
|
4.1M
|
43
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
RaceOncology
|
391 |
84K |
34 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
391
|
84K
|
34
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
RaceOncology
|
168 |
48K |
11 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
168
|
48K
|
11
|
|
ASX - By Stock
|
RAC |
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
RaceOncology
|
391 |
84K |
108 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
391
|
84K
|
108
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
RaceOncology
|
2.2K |
777K |
48 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
2.2K
|
777K
|
48
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
11K |
4.1M |
28 |
03/07/24 |
03/07/24 |
General
|
11K
|
4.1M
|
28
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
RaceOncology
|
2.2K |
777K |
20 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
2.2K
|
777K
|
20
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
11K |
4.1M |
35 |
03/07/24 |
03/07/24 |
General
|
11K
|
4.1M
|
35
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
11K |
4.1M |
58 |
03/07/24 |
03/07/24 |
General
|
11K
|
4.1M
|
58
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
RaceOncology
|
168 |
48K |
118 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
168
|
48K
|
118
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
RaceOncology
|
130 |
38K |
37 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
130
|
38K
|
37
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 GLP Non-clinical Toxicology Program Successful
|
|
RaceOncology
|
80 |
25K |
62 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
80
|
25K
|
62
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 GLP Non-clinical Toxicology Program Successful
|
|
RaceOncology
|
80 |
25K |
53 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
80
|
25K
|
53
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 GLP Non-clinical Toxicology Program Successful
|
|
RaceOncology
|
80 |
25K |
100 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
80
|
25K
|
100
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 GLP Non-clinical Toxicology Program Successful
|
|
RaceOncology
|
80 |
25K |
75 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
80
|
25K
|
75
|
|